Karin Hehenberger
Director/Board Member chez AADI BIOSCIENCE, INC.
Fortune : 9 801 $ au 31/03/2024
Provenance du réseau au premier degré de Karin Hehenberger
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 19 | |
| Public Company | Pharmaceuticals: Major | 13 | |
| Public Company | Pharmaceuticals: Major | 8 | |
Aadi Subsidiary, Inc.
 Aadi Subsidiary, Inc. BiotechnologyHealth Technology Aadi Subsidiary, Inc. engages in biopharmaceutical company. Its therapeutic programs include pulmonary arterial hypertension, pediatric solid tumors, solid tumors with mTOR activation and mitochondrial disease. The company was founded by Neil Desai and is headquartered in Pacific Palisades, CA.
8
| Subsidiary | Biotechnology | 8 |
AnaCardio AB
 AnaCardio AB Pharmaceuticals: MajorHealth Technology AnaCardio AB is a clinical stage biopharmaceutical company based in Stockholm, Sweden. AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility to treat heart failure, a progressive cardiac syndrome affecting more than six million individuals in the US and nearly 100 million worldwide. The Swedish company's unique solution is based on the ghrelin signaling pathway, intended to increase contractility without causing adverse tachycardia, arrhythmia, ischemia, or hypotension. The company was founded by Lars Lund and is currently led by CEO Patrik Strömberg since 2021.
7
| Holding Company | Pharmaceuticals: Major | 7 |
Amal Therapeutics SA
 Amal Therapeutics SA BiotechnologyHealth Technology Amal Therapeutics SA engages in the development of peptide-based therapeutic cancer vaccines. It offers KISMA, a novel peptide/protein-based immunization technology platform, which is self-adjuvanting and enables the assembly within one chimeric fusion protein of elements essential to generate potent immunity. The company was founded by Madiha Derouazi on September 3, 2012 and is headquartered in Geneva, Switzerland.
4
| Subsidiary | Biotechnology | 4 |
Scandinavian Life Science Ventures AB
 Scandinavian Life Science Ventures AB Investment ManagersFinance SLS Invest AB (SLS Invest) is a venture capital firm wholly-owned by Sjätte AP-fonden. The firm was established in 2007 and is headquartered in Stockholm, Sweden, with a branch office in Copenhagen, Denmark.
3
| Extinct | Investment Managers | 3 |
Rolf Lufts Stiftelse Foer Diabetesforskning
2
| Private Company | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Karin Hehenberger via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| CELGENE | Biotechnology | General Counsel Corporate Officer/Principal Corporate Officer/Principal | |
| IMMUNOMEDICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Chairman Corporate Officer/Principal Corporate Officer/Principal | |
| PAREXEL INTERNATIONAL CORPORATION | Miscellaneous Commercial Services | Director of Finance/CFO Director of Finance/CFO | |
| THE MEDICINES COMPANY | Pharmaceuticals: Major | General Counsel General Counsel | |
Gyros AB
 Gyros AB Medical SpecialtiesHealth Technology Gyros AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. Its Gyrolab xP miniaturizes, integrates, and automates analysis of samples in parallel. The firm's technology delivers immunoassay data through automated control of centrifugal and capillary forces to steer liquid flow in proprietary nanoliter-scale microfluidic structures.The company offers Gyrolab microlaboratory, in the form of a compact disk, can process samples at nanoliter scale, controlled by Gyrolab Workstation. Gyros was founded in 2000 and is headquartered in Uppsala, Sweden. | Medical Specialties | Chairman Director/Board Member | |
| GENTIUM S.P.A. (ADR) | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
APP Pharmaceuticals, Inc.
 APP Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology APP Pharmaceuticals, Inc. develops, manufactures and markets injectable pharmaceutical products with a primary focus on the oncology, anti-infective, anesthetic/analgesic and critical care markets. It offers one of the most comprehensive product portfolios used in hospitals, long-term care facilities, alternate care sites and clinics within North America and manufactures a comprehensive range of dosage formulations. The company is headquartered in Los Angeles, CA. | Pharmaceuticals: Major | Chief Administrative Officer General Counsel | |
Aerpio Therapeutics, Inc.
 Aerpio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerpio Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases. The firm develops small molecules and monoclonal antibodies for the treatment of vascular disease and enhancement of wound healing. Its two lead programs include a tie-2 activator for diabetic macular edema and vascular leak, and a hypoxia-inducible factor 1-a stabilizer for wound healing and the treatment of inflammatory bowel disease. The company was founded by Joseph H. Gardner and Robert Shalwitz in 2011 and is headquartered in Cincinnati, OH. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| MEDIVIR AB | Pharmaceuticals: Major | President Chief Tech/Sci/R&D Officer | |
| Imperial College London | College/University | Undergraduate Degree Undergraduate Degree | |
Industrifonden
 Industrifonden Investment ManagersFinance Industrifonden is a Venture Capital firm, a subsidiary of Government of Sweden founded in 1979. The firm is headquartered in Stockholm. | Investment Managers | Private Equity Investor | |
| Karolinska Institutet | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
| University of California, Los Angeles | College/University | Corporate Officer/Principal Doctorate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Doctorate Degree | |
| University of Maryland | College/University | Undergraduate Degree Undergraduate Degree | |
| The University of California, San Francisco | College/University | Doctorate Degree Doctorate Degree | |
| Stockholm School of Economics | College/University | Masters Business Admin Masters Business Admin | |
| University of Uppsala | College/University | Graduate Degree Undergraduate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree Doctorate Degree | |
Newron Sweden AB
 Newron Sweden AB Pharmaceuticals: MajorHealth Technology Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer | |
University of Linköping
 University of Linköping Other Consumer ServicesConsumer Services Linköping University Hospital provides healthcare services. | College/University | Graduate Degree Doctorate Degree | |
| University of Lund | College/University | Graduate Degree Doctorate Degree Graduate Degree Doctorate Degree | |
Masimo Sweden AB
 Masimo Sweden AB Electronic Equipment/InstrumentsElectronic Technology Masimo Sweden AB develops and markets ultra-small gas monitoring probes. It sells mobile multigas analyzers that enable to measure respiratory gases in any clinical application. The firms products include IRMA Mainstream Analyzers, ISA Sidestream Analyzers, Nomoline Sampling Lines, EMMA Capnometers, and EMMA Carnograph. The company was founded by Anders Eckerbom and Robert Zyzanski in 1989 and is headquartered in Danderyd, Sweden. | Electronic Equipment/Instruments | Director/Board Member Director/Board Member | |
| University of Gothenburg | College/University | Graduate Degree Doctorate Degree | |
Kearny Venture Partners
 Kearny Venture Partners Investment ManagersFinance Kearny Venture Partners (Kearny Venture Partners) is a venture capital firm. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
| CONSTELLATION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
NewBridge Pharmaceuticals FZ LLC
 NewBridge Pharmaceuticals FZ LLC Pharmaceuticals: MajorHealth Technology NewBridge Pharmaceuticals FZ LLC engages in the manufacture and distribution of pharmaceutical products, therapeutics and medical devices. The company was founded by G. Garrett Vygantas in 2007 and is headquartered in Dubai, United Arab Emirates. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree | |
Umecrine Cognition AB
 Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Umecrine Cognition AB develops pharmaceuticals against neurological disorders in the central nervous system. The firm focuses on the development and commercialization of novel therapeutics to treat Hepatic Encephalopathy in patients with liver disease. The company was founded by Torbjörn Bäckström in 2006 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Founder Director/Board Member | |
| KANCERA AB | Pharmaceuticals: Major | Director/Board Member Chairman Chief Tech/Sci/R&D Officer | |
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Chief Tech/Sci/R&D Officer General Counsel | |
| Boston University School of Law | College/University | Graduate Degree Graduate Degree | |
| GUARD THERAPEUTICS INTERNATIONAL AB | Pharmaceuticals: Major | Director/Board Member | |
Modus Therapeutics AB
 Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin Masters Business Admin | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree | |
Sanofi AB
 Sanofi AB Medical DistributorsDistribution Services Part of Sanofi, Sanofi AB is a pharmaceutical company based in Stockholm, Sweden. The Swedish company's description states that it is an international pharmaceutical company. | Medical Distributors | Sales & Marketing | |
| NEXTCELL PHARMA AB | Pharmaceuticals: Major | Chairman Director/Board Member | |
Recipharm OT Chemistry AB
 Recipharm OT Chemistry AB Pharmaceuticals: MajorHealth Technology Part of Recipharm AB, Recipharm OT Chemistry AB develops and manufactures drug dosage forms and inhalation products & devices. The private company is based in Uppsala, Sweden. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ONCOZENGE AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
AI Proteins, Inc.
 AI Proteins, Inc. Pharmaceuticals: MajorHealth Technology AI Proteins, Inc. is a biotech company based in Andover, MA. AI Proteins is focused on re-imagining protein therapeutics by designing entirely new proteins using an AI-based approach and a high-throughput drug discovery platform. The company's platform enables the development of inexpensive, durable, and highly specific proteins optimized for specific therapeutic applications. These proteins have the potential for oral delivery and can dramatically accelerate the development of lead therapeutic candidates ready for IND-enabling studies. The company was founded by Marc A. Cohen and Christopher Bahl. Noah D. Beerman has been the CEO of the company since 2023. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer |
Statistiques
Internationale
| Etats-Unis | 26 |
| Suède | 22 |
| Italie | 2 |
| Royaume-Uni | 2 |
| Emirats Arabes Unis | 2 |
Sectorielle
| Health Technology | 28 |
| Consumer Services | 16 |
| Finance | 5 |
| Commercial Services | 2 |
| Electronic Technology | 2 |
Opérationnelle
| Director/Board Member | 264 |
| Corporate Officer/Principal | 107 |
| Chairman | 49 |
| Independent Dir/Board Member | 48 |
| Chief Executive Officer | 44 |
Relations les plus connectées
| Insiders | |
|---|---|
| Erik Kjellsson Nerpin | 79 |
| Bobby Sandage | 29 |
| Richard E. Maroun | 27 |
| Caley Castelein | 23 |
| Harlan Weisman | 20 |
| Emma Reeve | 18 |
| Jonas Frick | 18 |
| Anupam Dalal | 18 |
| Alan Henry Raffensperger | 17 |
| Fredrik Lehmann | 17 |
| Per Carendi | 16 |
| Xiao Qin Lu | 15 |
| Hans Johan Albert von Kantzow | 15 |
| Mohammad Hirmand | 14 |
| Carlo Montagner | 13 |
- Bourse
- Insiders
- Karin Hehenberger
- Connexions Sociétés
